课题基金 / 基金详情

Expensive Orphan Drugs and Translational Research in Rare Diseases

Expensive Orphan Drugs and Translational Research in Rare Diseases
昂贵的孤儿药和罕见疾病的转化研究
批准号:
283782
负责人:
McGuire Marlene
金额:
$10.93万
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-10-01 至 2015-10-01

项目摘要

项目成果

McGuire Marlene的其他基金

相似基金

相关文献

中文摘要
翻译
了解制药发展对了解我们医疗系统的现状和未来方向至关重要。通过一个多地点的人种学项目,我打算探索wha研究和发展的动态,
英文摘要
Understanding pharmaceutical development is vitally important to understanding the current state and future directions of our medical system. Through an ethnographic, multi-sited project, I intend to explore the dynamics of research and development of wha
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Patient input & transparency in rare disease drug reimbursement decision-making: an international comparator
Expensive Orphan Drugs and Translational Research in Rare Diseases
  • 批准号:
    283739
  • 项目类别:
    Studentship Programs
  • 资助金额:
    $3.28万
  • 财政年份:
    2012
  • 负责人:
    McGuire Marlene
  • 依托单位:
海外基金